These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 24661561)

  • 1. Detection of changes in the locus coeruleus in patients with mild cognitive impairment and Alzheimer's disease: high-resolution fast spin-echo T1-weighted imaging.
    Takahashi J; Shibata T; Sasaki M; Kudo M; Yanezawa H; Obara S; Kudo K; Ito K; Yamashita F; Terayama Y
    Geriatr Gerontol Int; 2015 Mar; 15(3):334-40. PubMed ID: 24661561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Magnetic resonance imaging Locus Coeruleus abnormality in amnestic Mild Cognitive Impairment is associated with future progression to dementia.
    Galgani A; Lombardo F; Martini N; Vergallo A; Bastiani L; Hampel H; Hlavata H; Baldacci F; Tognoni G; De Marchi D; Ghicopulos I; De Cori S; Biagioni F; Busceti CL; Ceravolo R; Bonuccelli U; Chiappino D; Siciliano G; Fornai F; Pavese N; Giorgi FS
    Eur J Neurol; 2023 Jan; 30(1):32-46. PubMed ID: 36086917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Locus coeruleus cellular and molecular pathology during the progression of Alzheimer's disease.
    Kelly SC; He B; Perez SE; Ginsberg SD; Mufson EJ; Counts SE
    Acta Neuropathol Commun; 2017 Jan; 5(1):8. PubMed ID: 28109312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brainstem substructures and cognition in prodromal Alzheimer's disease.
    Dutt S; Li Y; Mather M; Nation DA;
    Brain Imaging Behav; 2021 Oct; 15(5):2572-2582. PubMed ID: 33646514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mild cognitive impairment in de novo Parkinson's disease: A neuromelanin MRI study in locus coeruleus.
    Li Y; Wang C; Wang J; Zhou Y; Ye F; Zhang Y; Cheng X; Huang Z; Liu K; Fei G; Zhong C; Zeng M; Jin L
    Mov Disord; 2019 Jun; 34(6):884-892. PubMed ID: 30938892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MRI-assessed locus coeruleus integrity is heritable and associated with multiple cognitive domains, mild cognitive impairment, and daytime dysfunction.
    Elman JA; Puckett OK; Beck A; Fennema-Notestine C; Cross LK; Dale AM; Eglit GML; Eyler LT; Gillespie NA; Granholm EL; Gustavson DE; Hagler DJ; Hatton SN; Hauger R; Jak AJ; Logue MW; McEvoy LK; McKenzie RE; Neale MC; Panizzon MS; Reynolds CA; Sanderson-Cimino M; Toomey R; Tu XM; Whitsel N; Williams ME; Xian H; Lyons MJ; Franz CE; Kremen WS
    Alzheimers Dement; 2021 Jun; 17(6):1017-1025. PubMed ID: 33580733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between small cerebral white matter lesions and cognitive function in patients with Alzheimer's disease and amnestic mild cognitive impairment.
    Makino T; Umegaki H; Suzuki Y; Yanagawa M; Nonogaki Z; Nakashima H; Kuzuya M
    Geriatr Gerontol Int; 2014 Oct; 14(4):819-26. PubMed ID: 24215176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Awareness disorders in Alzheimer's disease and in mild cognitive impairment].
    Jacus JP; Dupont MP; Herades Y; Pelix C; Large H; Baud M
    Encephale; 2014 Apr; 40(2):180-7. PubMed ID: 24630532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal Cognitive Decline in Patients With Mild Cognitive Impairment or Dementia Due to Alzheimer's Disease.
    Lim YY; Kong J; Maruff P; Jaeger J; Huang E; Ratti E
    J Prev Alzheimers Dis; 2022; 9(1):178-183. PubMed ID: 35098989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cingulum correlates of cognitive functions in patients with mild cognitive impairment and early Alzheimer's disease: a diffusion spectrum imaging study.
    Lin YC; Shih YC; Tseng WY; Chu YH; Wu MT; Chen TF; Tang PF; Chiu MJ
    Brain Topogr; 2014 May; 27(3):393-402. PubMed ID: 24414091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of amyloid on memory and non-memory decline from preclinical to clinical Alzheimer's disease.
    Lim YY; Maruff P; Pietrzak RH; Ames D; Ellis KA; Harrington K; Lautenschlager NT; Szoeke C; Martins RN; Masters CL; Villemagne VL; Rowe CC;
    Brain; 2014 Jan; 137(Pt 1):221-31. PubMed ID: 24176981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Examining the Role of the Noradrenergic Locus Coeruleus for Predicting Attention and Brain Maintenance in Healthy Old Age and Disease: An MRI Structural Study for the Alzheimer's Disease Neuroimaging Initiative.
    Plini ERG; O'Hanlon E; Boyle R; Sibilia F; Rikhye G; Kenney J; Whelan R; Melnychuk MC; Robertson IH; Dockree PM
    Cells; 2021 Jul; 10(7):. PubMed ID: 34359997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early diagnosis of Alzheimer's disease using cortical thickness: impact of cognitive reserve.
    Querbes O; Aubry F; Pariente J; Lotterie JA; Démonet JF; Duret V; Puel M; Berry I; Fort JC; Celsis P;
    Brain; 2009 Aug; 132(Pt 8):2036-47. PubMed ID: 19439419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic and Prognostic Value of the Combination of Two Measures of Verbal Memory in Mild Cognitive Impairment due to Alzheimer's Disease.
    Sala I; Illán-Gala I; Alcolea D; Sánchez-Saudinós MB; Salgado SA; Morenas-Rodríguez E; Subirana A; Videla L; Clarimón J; Carmona-Iragui M; Ribosa-Nogué R; Blesa R; Fortea J; Lleó A
    J Alzheimers Dis; 2017; 58(3):909-918. PubMed ID: 28527215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Memory performance on the story recall test and prediction of cognitive dysfunction progression in mild cognitive impairment and Alzheimer's dementia.
    Park JH; Park H; Sohn SW; Kim S; Park KW
    Geriatr Gerontol Int; 2017 Oct; 17(10):1603-1609. PubMed ID: 27910252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemogenetic locus coeruleus activation restores reversal learning in a rat model of Alzheimer's disease.
    Rorabaugh JM; Chalermpalanupap T; Botz-Zapp CA; Fu VM; Lembeck NA; Cohen RM; Weinshenker D
    Brain; 2017 Nov; 140(11):3023-3038. PubMed ID: 29053824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous imaging of locus coeruleus and substantia nigra with a quantitative neuromelanin MRI approach.
    Chen X; Huddleston DE; Langley J; Ahn S; Barnum CJ; Factor SA; Levey AI; Hu X
    Magn Reson Imaging; 2014 Dec; 32(10):1301-6. PubMed ID: 25086330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Automated MRI measures identify individuals with mild cognitive impairment and Alzheimer's disease.
    Desikan RS; Cabral HJ; Hess CP; Dillon WP; Glastonbury CM; Weiner MW; Schmansky NJ; Greve DN; Salat DH; Buckner RL; Fischl B;
    Brain; 2009 Aug; 132(Pt 8):2048-57. PubMed ID: 19460794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. White matter signal abnormality quality differentiates mild cognitive impairment that converts to Alzheimer's disease from nonconverters.
    Lindemer ER; Salat DH; Smith EE; Nguyen K; Fischl B; Greve DN;
    Neurobiol Aging; 2015 Sep; 36(9):2447-57. PubMed ID: 26095760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinal plasma p-tau217 is increased in early stages of Alzheimer's disease.
    Mattsson-Carlgren N; Janelidze S; Palmqvist S; Cullen N; Svenningsson AL; Strandberg O; Mengel D; Walsh DM; Stomrud E; Dage JL; Hansson O
    Brain; 2020 Dec; 143(11):3234-3241. PubMed ID: 33068398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.